DK0693070T3 - Pyrido[2,3-b][1,4]benzodiazepinoner som M2-receptorligand til behandling af neurologiske lidelser - Google Patents
Pyrido[2,3-b][1,4]benzodiazepinoner som M2-receptorligand til behandling af neurologiske lidelserInfo
- Publication number
- DK0693070T3 DK0693070T3 DK94914039T DK94914039T DK0693070T3 DK 0693070 T3 DK0693070 T3 DK 0693070T3 DK 94914039 T DK94914039 T DK 94914039T DK 94914039 T DK94914039 T DK 94914039T DK 0693070 T3 DK0693070 T3 DK 0693070T3
- Authority
- DK
- Denmark
- Prior art keywords
- treatment
- neurological disorders
- benzodiazepinones
- pyrido
- receptor ligand
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- External Artificial Organs (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US4287293A | 1993-04-05 | 1993-04-05 | |
PCT/US1994/003720 WO1994022861A1 (fr) | 1993-04-05 | 1994-04-05 | PYRIDO[2,3-b][1,4]BENZODIAZEPINONES EN TANT QUE LIGAND DE RECEPTEUR M2 POUR LE TRAITEMENT DE TROUBLES NEUROLOGIQUES |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0693070T3 true DK0693070T3 (da) | 2002-11-11 |
Family
ID=21924192
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK94914039T DK0693070T3 (da) | 1993-04-05 | 1994-04-05 | Pyrido[2,3-b][1,4]benzodiazepinoner som M2-receptorligand til behandling af neurologiske lidelser |
Country Status (11)
Country | Link |
---|---|
US (1) | US5712269A (fr) |
EP (2) | EP0693070B1 (fr) |
JP (1) | JP3638950B2 (fr) |
AT (1) | ATE221067T1 (fr) |
AU (1) | AU688318B2 (fr) |
CA (1) | CA2159815A1 (fr) |
DE (1) | DE69431050T2 (fr) |
DK (1) | DK0693070T3 (fr) |
ES (1) | ES2180575T3 (fr) |
PT (1) | PT693070E (fr) |
WO (1) | WO1994022861A1 (fr) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6528529B1 (en) | 1998-03-31 | 2003-03-04 | Acadia Pharmaceuticals Inc. | Compounds with activity on muscarinic receptors |
ITMI991452A1 (it) * | 1999-07-01 | 2001-01-01 | Mediolanum Farmaceutici Srl | Antagonisti selettivi per i recettori m2 con struttura 5h-dibenzo b,fazepinica |
AR025884A1 (es) | 1999-10-01 | 2002-12-18 | Takeda Pharmaceutical | Compuestos de amina ciclica, su produccion y su uso |
WO2003089004A1 (fr) * | 2002-04-19 | 2003-10-30 | Takeda Pharmaceutical Company Limited | Agents prophylactiques utilises pour prevenir l'infection par vih |
JP5064216B2 (ja) | 2004-07-16 | 2012-10-31 | プロテオシス・アーゲー | 炎症性疾患用治療剤としての、parp及びsir調節活性を有するムスカリンアンタゴニスト |
JP2009506069A (ja) | 2005-08-26 | 2009-02-12 | ブレインセルス,インコーポレイティド | ムスカリン性受容体調節による神経発生 |
EP2258359A3 (fr) | 2005-08-26 | 2011-04-06 | Braincells, Inc. | Neurogenèse par modulation des récepteurs muscariniques avec sabcomeline |
KR20200022525A (ko) * | 2008-12-04 | 2020-03-03 | 충시 위 | 고투과력을 가진 조성물 및 이의 적용 |
WO2010081825A2 (fr) | 2009-01-13 | 2010-07-22 | Proteosys Ag | Pirenzépine en tant qu'agent utilisé dans le traitement du cancer |
GB201510010D0 (en) | 2015-06-09 | 2015-07-22 | King S College London | PDD and BPD compounds |
US20180339985A1 (en) | 2015-08-21 | 2018-11-29 | Femtogenix Limited | Pdd compounds |
GB201514928D0 (en) | 2015-08-21 | 2015-10-07 | King S College London | PDD compounds |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH438343A (de) * | 1962-11-08 | 1967-06-30 | Thomae Gmbh Dr K | Verfahren zur Herstellung von 5,6-Dihydro-6-oxo-11H-pyrido (2,3-b) (1,4)-benzodiazepinen |
DE3735895A1 (de) * | 1987-10-23 | 1989-05-03 | Thomae Gmbh Dr K | Kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
DE3818299A1 (de) * | 1988-05-30 | 1989-12-07 | Thomae Gmbh Dr K | Neue kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
GB9000302D0 (en) * | 1990-01-06 | 1990-03-07 | Pfizer Ltd | Muscarinic receptor antagonists |
DE4112014A1 (de) * | 1991-04-12 | 1992-10-15 | Thomae Gmbh Dr K | Kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende mittel zur behandlung von erkrankungen des zentralnervensystems und zur foerderung der cerebralen durchblutung |
-
1994
- 1994-04-05 AU AU66261/94A patent/AU688318B2/en not_active Ceased
- 1994-04-05 EP EP94914039A patent/EP0693070B1/fr not_active Expired - Lifetime
- 1994-04-05 CA CA002159815A patent/CA2159815A1/fr not_active Abandoned
- 1994-04-05 DE DE69431050T patent/DE69431050T2/de not_active Expired - Fee Related
- 1994-04-05 AT AT94914039T patent/ATE221067T1/de not_active IP Right Cessation
- 1994-04-05 ES ES94914039T patent/ES2180575T3/es not_active Expired - Lifetime
- 1994-04-05 WO PCT/US1994/003720 patent/WO1994022861A1/fr active IP Right Grant
- 1994-04-05 DK DK94914039T patent/DK0693070T3/da active
- 1994-04-05 JP JP52246994A patent/JP3638950B2/ja not_active Expired - Fee Related
- 1994-04-05 EP EP01200454A patent/EP1120416A1/fr not_active Withdrawn
- 1994-04-05 PT PT94914039T patent/PT693070E/pt unknown
-
1995
- 1995-01-24 US US08/377,667 patent/US5712269A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2159815A1 (fr) | 1994-10-13 |
PT693070E (pt) | 2002-12-31 |
JP3638950B2 (ja) | 2005-04-13 |
JPH08510999A (ja) | 1996-11-19 |
EP0693070B1 (fr) | 2002-07-24 |
ATE221067T1 (de) | 2002-08-15 |
DE69431050T2 (de) | 2003-03-13 |
EP1120416A1 (fr) | 2001-08-01 |
ES2180575T3 (es) | 2003-02-16 |
WO1994022861A1 (fr) | 1994-10-13 |
DE69431050D1 (de) | 2002-08-29 |
AU6626194A (en) | 1994-10-24 |
AU688318B2 (en) | 1998-03-12 |
EP0693070A1 (fr) | 1996-01-24 |
US5712269A (en) | 1998-01-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ330023A (en) | Fused pyrrolecarboxanilides and their use as a GABA brain receptor ligands | |
TWI224595B (en) | New benzazepine derivatives, drugs containing these and use of the same for producing drugs | |
FI990207A (fi) | Enantiomeeripuhtaat diatsabisyklo(4.3.0)nonaanijohdannaiset | |
DZ2370A1 (fr) | Procédé de préparation d'hydrocarbures | |
DK0693070T3 (da) | Pyrido[2,3-b][1,4]benzodiazepinoner som M2-receptorligand til behandling af neurologiske lidelser | |
FR2707087B1 (fr) | Nouveau procédé de préparation de l'ergothionéine. | |
BG95241A (bg) | Метод за получаване на 2,9-дизаместени-4н-пиридо/1.2-а/ пиримидин-4-они | |
NO180587C (no) | Fremgangsmåte for fremstilling av 5-substituerte pyrrolo(2,3-d)pyrimidiner | |
CA2167004A1 (fr) | Agent pour le traitement de troubles mentaux associes a des troubles cerebrovasculaires | |
ATE178332T1 (de) | Benzothiadiazinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zuzammensetzungen | |
AU2338992A (en) | Carbonate-substituted imidazo(4,5-d) pyridazine compounds for treatment of cardiovascular disorders | |
AU7346694A (en) | Method for preparing photochromic compounds of the spiro{indolin-{2,3'}-benzoxazine} ringed type | |
WO1999024026A3 (fr) | Methode de traitement des troubles lies a l'apoptose au moyen de composes de glyoxylamide n-heterocycliques | |
DZ2202A1 (fr) | Procédé de préparation d'énantiomères purs d'acides cyclo-alcano-indol-azaindol-et pyrimido (1,2-a) indol-carbocyclique et leurs dérivés actives. | |
FR2721598B1 (fr) | Procédé de préparation de catalyseurs d'ammoxydation. | |
DK0935598T3 (da) | 5-heteroatom-alkylsubstituerede 3-oxopyrido(1,2-a)benzimidazol-4-carboxamidderivater egnede til behandling af sygdomme i centralnervesystemet | |
FR2708266B1 (fr) | Procédé de préparation d'alcanesulfonamides. | |
ZA963132B (en) | Process for the preparation of pure enantiomers of 1-2-pyridyl)-2-cyclo-hexylethylamine. | |
DZ2423A1 (fr) | Procédé pour la préparation d'acides 4-phényl-4-cyanocyclohexanoiques substitués. | |
AU6581294A (en) | Ethanolamine derivatives useful for the treatment of gastrointestinal disorders | |
FI914923A0 (fi) | Foerfarande foer framstaellning av 5,11 -dihydro-6h-dipyrido-/3,2-b:2',3'-e//1,4/diazepiner. knippe. | |
PH24501A (en) | Substituted 3-phenyl-7h-thiazolo(3,2-b)(1,2,4)triazin-7-ones | |
IT1296613B1 (it) | Farmaco per la cura dell'ircismo contenente un adrenocorticosteroide. | |
FR2695388B1 (fr) | Dérivés de 1,3,4-benzotriazépin-5(4H)-one et procédé pour leur préparation. | |
HU9204112D0 (en) | Method for producing new benzole derivatives condensed with 5-member ring as well as pharmaceutical preparatives containing these compounds |